Uncontrolled Hypertension and Hyperkalemia Related to Low Dose Daily Acetylsalicylic Acid Therapy in a Patient with Coronary Artery Disease: A Case Report
M. Bilici, F. Yılmaz, I. Oz, S. Ilikhan, Başak Delikanli Çorakçi, Yasin Öztürk, A. Borazan
{"title":"Uncontrolled Hypertension and Hyperkalemia Related to Low Dose Daily Acetylsalicylic Acid Therapy in a Patient with Coronary Artery Disease: A Case Report","authors":"M. Bilici, F. Yılmaz, I. Oz, S. Ilikhan, Başak Delikanli Çorakçi, Yasin Öztürk, A. Borazan","doi":"10.5262/TNDT.2018.2662","DOIUrl":null,"url":null,"abstract":"Acetylsalicylic acid (ASA) is a member of the non-steroidal anti-inflammatory drugs (NSAIDs). Thus, it can cause side effects such as fluid, electrolyte and acid-base imbalances through the enzyme cyclooxygenases (COX 1-2). Despite the wide use of ASA and its general good safety profile, sensitivity to ASA should be kept in mind. Here, we reported a patient who presented with hypertension and hyperkalemia after low dose ASA treatment.","PeriodicalId":42328,"journal":{"name":"Turkish Nephrology Dialysis and Transplantation Journal","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkish Nephrology Dialysis and Transplantation Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5262/TNDT.2018.2662","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1
Abstract
Acetylsalicylic acid (ASA) is a member of the non-steroidal anti-inflammatory drugs (NSAIDs). Thus, it can cause side effects such as fluid, electrolyte and acid-base imbalances through the enzyme cyclooxygenases (COX 1-2). Despite the wide use of ASA and its general good safety profile, sensitivity to ASA should be kept in mind. Here, we reported a patient who presented with hypertension and hyperkalemia after low dose ASA treatment.